Executive Order on Promoting Competition in the American Economy: The Biden Administration Considers Drug Pricing Strategies While Keeping the “Most Favored Nations” Drug Reimbursement Program on the Sidelines (JSON)

lexblog.com/lib/B1GWD5P6view recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Executive Order on Promoting Competition in the American Economy:  The Biden Administration Considers Drug Pricing Strategies While Keeping the “Most Favored Nations” Drug Reimbursement Program on the Sidelines",
    "url": "https://www.lexblog.com/2021/08/20/biden-administration-considers-drug-pricing-strategies/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-B1GWD5P6",
        "url": "https://www.lexblog.com/lib/B1GWD5P6/"
    },
    "datePublished": "2021-08-20T18:07:44-04:00",
    "dateModified": "2025-04-29T16:13:18-04:00",
    "author": {
        "@type": "Person",
        "name": "Kathleen Stratton, Dhara Waghela"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Healthcare Law Blog",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.sheppardhealthlaw.com/?p=4962",
    "sourceStability": "may-move"
}